<li>arsenic trioxide<p>trazodone and arsenic trioxide both increase  QTc interval. Contraindicated.</p></li><li>astemizole<p>trazodone and astemizole both increase  QTc interval. Contraindicated.</p></li><li>cisapride<p>trazodone and cisapride both increase  QTc interval. Contraindicated.</p></li><li>disopyramide<p>trazodone and disopyramide both increase  QTc interval. Contraindicated.</p></li><li>eliglustat<p>trazodone increases levels of eliglustat by affecting hepatic enzyme CYP2D6 metabolism. Contraindicated. If coadministered with strong or moderate CYP2D6 inhibitors, reduce eliglustat dose from 84 mg BID to 84 mg once daily in extensive  and intermediate metabolizers;  eliglustat is contraindiated if strong or moderate CYP2D6 inhibitors are given concomitantly with strong or moderate CYP3A inhibitors.</p></li><li>ibutilide<p>trazodone and ibutilide both increase  QTc interval. Contraindicated.</p></li><li>indapamide<p>trazodone and indapamide both increase  QTc interval. Contraindicated.</p></li><li>isocarboxazid<p>isocarboxazid and trazodone both increase  serotonin levels. Contraindicated.</p></li><li>pentamidine<p>trazodone and pentamidine both increase  QTc interval. Contraindicated.</p></li><li>phenelzine<p>phenelzine and trazodone both increase  serotonin levels. Contraindicated.</p></li><li>pimozide<p>trazodone and pimozide both increase  QTc interval. Contraindicated.</p></li><li>procainamide<p>trazodone and procainamide both increase  QTc interval. Contraindicated.</p></li><li>procarbazine<p>procarbazine and trazodone both increase  serotonin levels. Contraindicated. Combination is contraindicated within 2 weeks of MAOI use.</p></li><li>quinidine<p>quinidine and trazodone both increase  QTc interval. Contraindicated.</p></li><li>safinamide<p>trazodone, safinamide.
Either increases toxicity of the other by serotonin levels. Contraindicated. Concomitant use could result in life-threatening serotonin syndrome.</p></li><li>saquinavir<p>trazodone will decrease the level or effect of saquinavir by  P-glycoprotein (MDR1) efflux transporter. Contraindicated.</p></li><li>sotalol<p>trazodone and sotalol both increase  QTc interval. Contraindicated.</p></li><li>terfenadine<p>trazodone and terfenadine both increase  QTc interval. Contraindicated.</p></li><li>tranylcypromine<p>tranylcypromine and trazodone both increase  serotonin levels. Contraindicated.</p></li>